Filtros de búsqueda

Lista de obras de V Navrkalova

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

artículo científico publicado en 2016

ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.

artículo científico publicado en 2013

Ability to downregulate the level of cyclin-dependent kinase inhibitor p27Kip1 after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway.

artículo científico publicado en 2016

Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification

artículo científico publicado en 2015

Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application

artículo científico publicado en 2021

Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab.

artículo científico publicado en 2014

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

artículo científico publicado en 2016

Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia

artículo científico publicado en 2014

Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients

artículo científico publicado en 2015

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

artículo científico publicado en 2015

Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients

artículo científico publicado en 2016

Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia

artículo científico publicado en 2012

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting

artículo científico publicado en 2014

The impact of SF3B1 mutations in CLL on the DNA-damage response

artículo científico publicado en 2014

The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells.

artículo científico publicado en 2013

[Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia]

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda